MapLight Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MPLT)

CUSIP: 56565P103

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+188
SEC-reported price per share
$10.19
Number of holders
4
Value change
+$634
Number of buys
3
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
53,015,891

Security key

56565P103

Report period

Q3 2026

Institutions

4

Top holders

4

Ownership snapshot

Top reported holders of MPLT - MapLight Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Catalyst4, Inc.
Disclosed value leader
Catalyst4, Inc.
Comparable rows
15/15
Latest evidence
14 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 50% 13D/G row: Catalyst4, Inc. Showing 1-6 of 15 holder rows.

Quick read

Catalyst4, Inc. leads the comparable SEC ownership view at 50%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Catalyst4, Inc.'s linked filing trail.
Comparable ownership Top 5
Catalyst4, Inc. 50%
T. Rowe Price Investment Manageme... 7.4%
Forbion Growth Opportunities Fund... 7.1%
Pivotal bioVenture Partners Fund ... 5.5%
Novo Holdings A/S 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Catalyst4, Inc.
13D/G 3/4/5
10%+ Owner
50%
$386,330,234
27,536,011 shares
+$93,009,388 14 Aug 2026
T. Rowe Price Investment Management, Inc.
13F 13D/G
Company
7.4%
from 13D/G
$99,698,000
2,781,728 shares
— 30 Jun 2026
Forbion Growth Opportunities Fund III Cooperatief U.A.
13D/G
7.1%
$61,527,448
3,226,400 shares
$0 31 Dec 2025
Pivotal bioVenture Partners Fund II, L.P.
13D/G
Nan Fung Group Holdings Limited
5.5%
$40,909,712
2,915,874 shares
$0 13 Aug 2026
Novo Holdings A/S
13F 13D/G 3/4/5
Company · 10%+ Owner
4.9%
from 13D/G
$132,128,532
3,686,622 shares
— 30 Jun 2026
FCPM III SERVICES B.V.
13F
Company
13F
6.1%
$115,634,176
3,226,400 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
4
Shares
14,605
Rows available
4
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q1 2026 Across Filers

Q1 2026 holders
80
Q3 2026 holders
4
Holder diff
-76
Investor Q1 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q1 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .